1. Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting Agent. (14th January 2023) Authors: Miyake, Makito; Nishimura, Nobutaka; Miyamoto, Tatsuki; Shimizu, Takuto; Ohnishi, Kenta; Hori, Shunta; Morizawa, Yosuke; Gotoh, Daisuke; Nakai, Yasushi; Torimoto, Kazumasa; Fujii, Tomomi; Fujimoto, Kiyohide Other Names: Koga Fumitaka Academic Editor. Journal: Case reports in urology Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗